Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Medical by Quarter
Medical (Acute Care Beds, Emergency Care LIFEPAK/LUCAS, Sage & Vocera) — U.S. Net Sales ($M) ($M)
Stryker Medical: $910M in Q3 2026, up 10.0% from a year earlier.
Latest, Q3 2026
910
Period ended Sep 30, 2026
Change on a year earlier
+10.0%
827 in Q3 2025
History
21 quarters
Since Q1 2021
Sources
7
Documents cited below
Where the Q3 2026 figure comes from
Reported in Stryker Form 8-K Supplemental Sales Schedules, Recast 8-K & Form 10-K/10-Q Note 15.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Medical (Acute Care Beds, Emergency Care LIFEPAK/LUCAS, Sage & Vocera) — U.S. Net Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 910 | +10.0% | 0000310764-26-000059|sykex991earningsq32026.htm ↗ |
| Q2 2026 | Jun 30, 2026 | 945 | +12.5% | 0000310764-26-000048|sykex991earningsq22026.htm ↗ |
| Q1 2026 | Mar 31, 2026 | 747 | -6.9% | 0000310764-26-000031|syk-20260331.htm ↗ |
| Q4 2025 | Dec 31, 2025 | 1,042 | +12.0% | ir|change_in_pres_2026Q1 ↗ |
| Q3 2025 | Sep 30, 2025 | 827 | +5.6% | ir|change_in_pres_2026Q1 ↗ |
| Q2 2025 | Jun 30, 2025 | 840 | +10.1% | ir|change_in_pres_2026Q1 ↗ |
| Q1 2025 | Mar 31, 2025 | 802 | +12.2% | ir|change_in_pres_2026Q1 ↗ |
| Q4 2024 | Dec 31, 2024 | 930 | +11.9% | ir|change_in_pres_2026Q1 ↗ |
| Q3 2024 | Sep 30, 2024 | 783 | +18.6% | ir|change_in_pres_2026Q1 ↗ |
| Q2 2024 | Jun 30, 2024 | 763 | +11.9% | ir|change_in_pres_2026Q1 ↗ |
| Q1 2024 | Mar 31, 2024 | 715 | +16.8% | ir|change_in_pres_2026Q1 ↗ |
| Q4 2023 | Dec 31, 2023 | 831 | – | ir|change_in_pres_2026Q1 ↗ |
| Q3 2023 | Sep 30, 2023 | 660 | +5.6% | ir|change_in_pres_2026Q1 ↗ |
| Q2 2023 | Jun 30, 2023 | 682 | +27.2% | ir|change_in_pres_2026Q1 ↗ |
| Q1 2023 | Mar 31, 2023 | 612 | +16.6% | ir|change_in_pres_2026Q1 ↗ |
| Q3 2022 | Sep 30, 2022 | 625 | +26.0% | 0000310764-22-000105|syk-20220930.htm ↗ |
| Q2 2022 | Jun 30, 2022 | 536 | +9.8% | 0000310764-22-000092|syk-20220630.htm ↗ |
| Q1 2022 | Mar 31, 2022 | 525 | +11.0% | 0000310764-22-000062|syk-20220331.htm ↗ |
| Q3 2021 | Sep 30, 2021 | 496 | – | 0000310764-22-000105|syk-20220930.htm ↗ |
| Q2 2021 | Jun 30, 2021 | 488 | – | 0000310764-22-000092|syk-20220630.htm ↗ |
| Q1 2021 | Mar 31, 2021 | 473 | – | 0000310764-22-000062|syk-20220331.htm ↗ |
Breakdown
What makes up medical
Cite this data
StockData. (2026). Stryker Medical ($M), quarterly Q1 2021–Q3 2026 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-med-us-rev
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.